ARWR
Arrowhead Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$8.56B
P/E Ratio
38.20
EPS
$1.60
Beta
1.27
52W High
$76.76
52W Low
$9.63
50-Day MA
$62.54
200-Day MA
$43.35
Dividend Yield
—
Profit Margin
18.50%
Forward P/E
97.09
PEG Ratio
-1.32
About Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California.
Fundamentals
| Revenue (TTM) | $1.09B |
| Gross Profit (TTM) | $1.09B |
| EBITDA | $325.65M |
| Operating Margin | 15.50% |
| Return on Equity | 75.50% |
| Return on Assets | 14.30% |
| Revenue/Share (TTM) | $7.97 |
| Book Value | $4.14 |
| Price-to-Book | 15.04 |
| Price-to-Sales (TTM) | 7.84 |
| EV/Revenue | 7.28 |
| EV/EBITDA | 21.46 |
| Quarterly Earnings Growth (YoY) | 9.80% |
| Quarterly Revenue Growth (YoY) | 10461.00% |
| Shares Outstanding | $140.03M |
| Float | $122.04M |
| % Insiders | 3.80% |
| % Institutions | 84.42% |
Analyst Ratings
Consensus ($81.09 target)
2
Strong Buy7
Buy3
HoldData last updated: 4/7/2026